Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
•To evaluate the efficacy of lebrikizumab compared with placebo in improving lung function, as measured by the absolute change in pre-bronchodilator forced expiratory volume in 1 second (FEV1), in adult patients with mild-to-moderate asthma treated with SABA only. •To evaluate the safety of lebrikizumab compared with placebo in patients with mild-to-moderate asthma treated with SABA only, focusing on the nature, frequency, and severity of serious and non-serious adverse events.
Inclusion criteria
- Asthma